NCT04033406View on ClinicalTrials.gov

Study of VIR-2482 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 26, 2019

Primary Completion Date

November 1, 2021

Study Completion Date

November 1, 2021

Conditions
Influenza A
Interventions
DRUG

VIR-2482

VIR-2482 given by intramuscular injection

DRUG

Placebo

Sterile normal saline (0.9% NaCl) given by intramuscular injection

Trial Locations (1)

Unknown

Investigative Site, Brisbane

All Listed Sponsors
lead

Vir Biotechnology, Inc.

INDUSTRY

NCT04033406 - Study of VIR-2482 in Healthy Volunteers | Biotech Hunter | Biotech Hunter